Explore more Norwegian companies →
COMPANY CARD COMPANY
EMBECTA NORWAY AS
Wholesale of pharmaceutical and medical goods
3,8 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Different financial year. Dates show the reporting period; figures are excluded from calendar-year growth and charts.
Amount in NOK
| Financial statement item | 01.10.2024–30.09.2025 | 01.10.2023–30.09.2024 | 01.10.2022–30.09.2023 |
|---|---|---|---|
| Currency | NOK | NOK | NOK |
| Operating revenue | 15 763 616 | 12 149 402 | 14 839 200 |
| Operating profit | 606 191 | 460 445 | 353 030 |
| Net income | 147 466 | 405 870 | 252 841 |
| Equity | 7 711 695 | 7 564 229 | 7 158 359 |
| Total assets | 10 014 578 | 9 731 646 | 9 368 547 |
| EBIT margin | 3,8 % | 3,8 % | 2,4 % |
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Chart requires at least two available years in NOK.
Chart requires at least two available years in NOK.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK-reported-fiscal-period · source version 081b419df396
- 2024 · NOK · original-NOK-reported-fiscal-period · source version 7c0cb15459dc
- 2023 · NOK · original-NOK-reported-fiscal-period · source version 8941da553cf6
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement14 entries with information
| Financial statement item | 01.10.2024–30.09.2025 | 01.10.2023–30.09.2024 | 01.10.2022–30.09.2023 |
|---|---|---|---|
| Operating revenue | |||
| Total sales revenue | 15 763 616 | 12 149 402 | 14 434 258 |
| Total operating revenue | 15 763 616 | 12 149 402 | 14 839 200 |
| Operating expenses | |||
| Wage costs | 0 | 184 570 | 808 540 |
| Total operating expenses | 15 157 425 | 11 688 958 | 14 486 170 |
| Operating profit | |||
| Operating income (EBIT) | 606 191 | 460 445 | 353 030 |
| Financial income | |||
| Total finance income | 54 790 | 237 981 | 7 253 |
| Financial expenses | |||
| Other interest expense | — | — | 3 |
| Interest expense to company in same group | 875 | 10 599 | 13 691 |
| Total finance costs | 57 618 | 20 591 | 55 152 |
| Net finance result | -2 828 | 217 390 | -47 899 |
| Results and tax | |||
| Income before tax | 603 363 | 677 835 | 305 131 |
| Tax expense on ordinary income | 455 897 | 271 965 | 52 290 |
| Net income | 147 466 | 405 870 | 252 841 |
| Total comprehensive income | 147 466 | 405 870 | 252 841 |
Balance sheet14 entries with information
| Financial statement item | 01.10.2024–30.09.2025 | 01.10.2023–30.09.2024 | 01.10.2022–30.09.2023 |
|---|---|---|---|
| Intangible assets | |||
| Goodwill | 0 | 0 | 0 |
| Financial fixed assets | |||
| Total non-current assets | 1 276 881 | 2 234 539 | 3 192 479 |
| Current assets | |||
| Total inventory | 0 | 9 018 | 92 747 |
| Total receivables | 2 539 840 | 4 471 727 | 2 281 144 |
| Total cash and cash equivalents | 6 197 857 | 3 016 362 | 3 802 177 |
| Total current assets | 8 737 697 | 7 497 106 | 6 176 068 |
| Total assets | 10 014 578 | 9 731 646 | 9 368 547 |
| Equity | |||
| Total paid-in equity | 7 028 262 | 7 028 262 | 7 028 262 |
| Total retained earnings | 683 433 | 535 967 | 130 097 |
| Total equity | 7 711 695 | 7 564 229 | 7 158 359 |
| Provisions and long-term liabilities | |||
| Total long-term liabilities | — | 0 | 0 |
| Current liabilities | |||
| Total current liabilities | 2 302 883 | 2 167 417 | 2 210 188 |
| Total liabilities | 2 302 883 | 2 167 417 | 2 210 188 |
| Total | |||
| Total equity and liabilities | 10 014 578 | 9 731 646 | 9 368 547 |
Executive salaryUnavailable
No information in the available financial statement data.
REGISTRY INFORMATION
Company at a glance
- Industry
- 46.460 · Wholesale of pharmaceutical and medical goods Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Haakon VIIs gate 6, 0161 OSLO
- Founded
- 29.07.2021
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Haakon VIIs gate 6, 0161 OSLO
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
| Name | Role | Source date |
|---|---|---|
| REVISORKONSULT ASView role record | Auditor | 17.11.2026 |
| Jeffrey Zimmerman MannBorn 1972 | Chair of the board | 17.11.2026 |
| KPMG ACCOUNTING ASView role record | Accountant | 17.11.2026 |
| Anke Edelgard BrouwersBorn 1973 | Board member | 17.11.2026 |
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
Ownership information is unavailable in this view. This does not mean the company has no owners.
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
Year-dated shareholder entries are unavailable in this source data. This does not mean the company has no owners or registered main entity.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.